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Table 1. Distribution of microbial etiology of CAP according to setting 
 
Microorganism Outpatients  
(%) 








20-35 18- 39 15- 22 5;11;  32;  
Mycoplasma pneumoniae 
 
1.3- 18 3- 10 2-3 5,11; 32; 
Chlamydophila pneumoniae 
 
1.8- 5 2-10 0-3 5 ;11 
Haemophilus influenzae 
 
1.5 - 10 4-5.5 3-4 5; 
Respiratory viruses 
 
13- 36 10-13 4-9 5; 11; 32 
Legionella spp. 
 
2 - 6 3.6- 7 8 -20 5; 11; 12; 32 
Polymicrobial infections 
 
0 - 9 10-14 11 - 20 5; 11; 32; 55 
Staphylococcus aureus 
 
0.5 1-2 1-3 5; 11 
Enteric gram-negative bacilli 
 
0 – 1.3 0.5-2 1-3 5;11;32 
Pseudomonas aeruginosa 
 
0.5 1-4 1-5 5; 11,32 
 
Table 2. Antimicrobial treatment for intracellular pathogens in severe CAP 
 
Pathogens Recommendation Antibiotic therapy 













Azithromycin + rifampicin 







Azithromycin or Doxycycline L 
 









Doxycycline or Azithromycin  
 
Levofloxacion or Chlarythromycin  







Levofloxacion or macrolide 
 
co-trimoxazole up until the final 6 weeks of pregnancy 
doxycycline and hydroxychloroquine postpartum for 12 months to women 
who develop a serologic profile of chronic Q fever 
 
* Imnunological complications for Mycoplasma pneumoniae is suggested used Corticosteroirds (Ref82). 
